LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Lebeau, Paul"
  2. AU="Dehghani, Sedigheh"
  3. AU="Ishibashi, Kenji"
  4. AU="Xu, Yanhua"
  5. AU="Matera, Katarzyna"
  6. AU="Ait-Ouarab, Slimane"
  7. AU="Nicola, Coppede"
  8. AU="Dewitt, John M"
  9. AU="Sorin M. Dudea"
  10. AU="Tanusha D. Ramdin"
  11. AU="Hao, Zehui"
  12. AU="Chauhan, Aman"

Search results

Result 1 - 10 of total 28

Search options

  1. Article ; Online: Repurposing Two Old Friends to Fight Cancer: Caffeine and Statins.

    Stouth, Derek W / Lebeau, Paul F / Austin, Richard C

    Cancer research

    2023  Volume 83, Issue 13, Page(s) 2091–2092

    Abstract: Statins are a class of cholesterol-lowering drugs that inhibit 3-hydroxy-3-methylglutaryl-CoA reductase, the rate-limiting enzyme of the mevalonate pathway. Evidence suggests that certain cancers depend on the mevalonate pathway for growth and survival, ... ...

    Abstract Statins are a class of cholesterol-lowering drugs that inhibit 3-hydroxy-3-methylglutaryl-CoA reductase, the rate-limiting enzyme of the mevalonate pathway. Evidence suggests that certain cancers depend on the mevalonate pathway for growth and survival, and thus blocking the mevalonate pathway with statins may offer a viable therapeutic approach for treating cancer, or at least enhance the efficacy of existing cancer drugs. In this issue of Cancer Research, Tran and colleagues showed that caffeine works jointly with FOXM1 inhibition to enhance the antitumor activity of statins in neuroblastoma cells. They found that caffeine synergizes with statins by suppressing statin-induced feedback activation of the mevalonate pathway. Here, we reflect on the potential of combining caffeine and statin drugs as a strategy for potentiating anticancer activity. See related article by Tran et al., p. 2248.
    MeSH term(s) Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Caffeine/pharmacology ; Mevalonic Acid/metabolism ; Drug Repositioning ; Friends ; Neuroblastoma/drug therapy ; Dietary Supplements ; Forkhead Box Protein M1
    Chemical Substances Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Caffeine (3G6A5W338E) ; Mevalonic Acid (S5UOB36OCZ) ; FOXM1 protein, human ; Forkhead Box Protein M1
    Language English
    Publishing date 2023-07-05
    Publishing country United States
    Document type Editorial ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 1432-1
    ISSN 1538-7445 ; 0008-5472
    ISSN (online) 1538-7445
    ISSN 0008-5472
    DOI 10.1158/0008-5472.CAN-23-1066
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Calcium as a reliable marker for the quantitative assessment of endoplasmic reticulum stress in live cells.

    Lebeau, Paul F / Platko, Khrystyna / Byun, Jae Hyun / Austin, Richard C

    The Journal of biological chemistry

    2021  Volume 296, Page(s) 100779

    Abstract: ... Calcium ( ... ...

    Abstract Calcium (Ca
    MeSH term(s) Calcium/analysis ; Calcium/metabolism ; Cell Line ; Endoplasmic Reticulum/metabolism ; Endoplasmic Reticulum Stress ; HEK293 Cells ; Hep G2 Cells ; Humans ; Microscopy, Fluorescence ; Unfolded Protein Response
    Chemical Substances Calcium (SY7Q814VUP)
    Language English
    Publishing date 2021-05-14
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1016/j.jbc.2021.100779
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: The Emerging Roles of Intracellular PCSK9 and Their Implications in Endoplasmic Reticulum Stress and Metabolic Diseases.

    Lebeau, Paul F / Platko, Khrystyna / Byun, Jae Hyun / Makda, Yumna / Austin, Richard C

    Metabolites

    2022  Volume 12, Issue 3

    Abstract: The importance of the proprotein convertase subtilisin/kexin type-9 ( ...

    Abstract The importance of the proprotein convertase subtilisin/kexin type-9 (
    Language English
    Publishing date 2022-02-26
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662251-8
    ISSN 2218-1989
    ISSN 2218-1989
    DOI 10.3390/metabo12030215
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book: Hommage à Paul Lebeau

    Lebeau, Paul

    Fac. de Pharmacie de Paris, 28. Nov. 1957

    (Annales pharmaceutiques Françaises ; 16,3, Suppl.)

    1958  

    Series title Annales pharmaceutiques Françaises ; 16,3, Suppl.
    Annales pharmaceutiques françaises
    Collection Annales pharmaceutiques françaises
    Language French
    Size 19 S. ; 8-o
    Publisher Masson
    Publishing place Paris
    Publishing country France
    Document type Book
    Note [Umschl.T.]
    HBZ-ID HT009028919
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  5. Article ; Online: MAPping the kinase landscape of macrophage activation.

    Platko, Khrystyna / Lebeau, Paul / Austin, Richard C

    The Journal of biological chemistry

    2018  Volume 293, Issue 25, Page(s) 9910–9911

    Abstract: ARL11 is a tumor suppressor gene with established pro-apoptotic properties, but its function beyond this role is poorly understood. A new analysis of macrophage activation has identified ARL11 as a novel regulator of a mitogen-activated protein kinase ( ... ...

    Abstract ARL11 is a tumor suppressor gene with established pro-apoptotic properties, but its function beyond this role is poorly understood. A new analysis of macrophage activation has identified ARL11 as a novel regulator of a mitogen-activated protein kinase (MAPK). These findings expand on the function of ARL11 beyond its tumor suppressor activity and highlight a novel role as a regulator of macrophage activation and inflammatory response.
    MeSH term(s) ADP-Ribosylation Factors/genetics ; ADP-Ribosylation Factors/metabolism ; Extracellular Signal-Regulated MAP Kinases/genetics ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Humans ; Lipopolysaccharides/pharmacology ; Macrophage Activation/drug effects ; Macrophages/drug effects ; Macrophages/enzymology ; Phosphorylation ; Signal Transduction ; p38 Mitogen-Activated Protein Kinases/genetics ; p38 Mitogen-Activated Protein Kinases/metabolism
    Chemical Substances Lipopolysaccharides ; Extracellular Signal-Regulated MAP Kinases (EC 2.7.11.24) ; p38 Mitogen-Activated Protein Kinases (EC 2.7.11.24) ; ADP-Ribosylation Factors (EC 3.6.5.2) ; ARL11 protein, human (EC 3.6.5.2)
    Language English
    Publishing date 2018-06-22
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.H118.003380
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A Metabolic Enhancer Protects against Diet-Induced Obesity and Liver Steatosis and Corrects a Pro-Atherogenic Serum Profile in Mice.

    Platko, Khrystyna / Lebeau, Paul F / Nederveen, Joshua P / Byun, Jae Hyun / MacDonald, Melissa E / Bourgeois, Jacqueline M / Tarnopolsky, Mark A / Austin, Richard C

    Nutrients

    2023  Volume 15, Issue 10

    Abstract: Objective: Metabolic Syndrome (MetS) affects hundreds of millions of individuals and constitutes a major cause of morbidity and mortality worldwide. Obesity is believed to be at the core of metabolic abnormalities associated with MetS, including ... ...

    Abstract Objective: Metabolic Syndrome (MetS) affects hundreds of millions of individuals and constitutes a major cause of morbidity and mortality worldwide. Obesity is believed to be at the core of metabolic abnormalities associated with MetS, including dyslipidemia, insulin resistance, fatty liver disease and vascular dysfunction. Although previous studies demonstrate a diverse array of naturally occurring antioxidants that attenuate several manifestations of MetS, little is known about the (i) combined effect of these compounds on hepatic health and (ii) molecular mechanisms responsible for their effect.
    Methods: We explored the impact of a metabolic enhancer (ME), consisting of 7 naturally occurring antioxidants and mitochondrial enhancing agents, on diet-induced obesity, hepatic steatosis and atherogenic serum profile in mice.
    Results: Here we show that a diet-based ME supplementation and exercise have similar beneficial effects on adiposity and hepatic steatosis in mice. Mechanistically, ME reduced hepatic ER stress, fibrosis, apoptosis, and inflammation, thereby improving overall liver health. Furthermore, we demonstrated that ME improved HFD-induced pro-atherogenic serum profile in mice, similar to exercise. The protective effects of ME were reduced in proprotein convertase subtilisin/kexin 9 (PCSK9) knock out mice, suggesting that ME exerts it protective effect partly in a PCSK9-dependent manner.
    Conclusions: Our findings suggest that components of the ME have a positive, protective effect on obesity, hepatic steatosis and cardiovascular risk and that they show similar effects as exercise training.
    MeSH term(s) Mice ; Animals ; Proprotein Convertase 9/metabolism ; Antioxidants/metabolism ; Diet, High-Fat/adverse effects ; Obesity/metabolism ; Liver/metabolism ; Metabolic Syndrome/etiology ; Metabolic Syndrome/prevention & control ; Metabolic Syndrome/metabolism ; Non-alcoholic Fatty Liver Disease/etiology ; Non-alcoholic Fatty Liver Disease/prevention & control ; Non-alcoholic Fatty Liver Disease/metabolism ; Insulin Resistance ; Mice, Inbred C57BL
    Chemical Substances PCSK9 protein, human (EC 3.4.21.-) ; Proprotein Convertase 9 (EC 3.4.21.-) ; Antioxidants
    Language English
    Publishing date 2023-05-22
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu15102410
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: The trypan blue cellular debris assay: a novel low-cost method for the rapid quantification of cell death

    Lebeau, Paul F / Chen, Jack / Byun, Jae Hyun / Platko, Khrystyna / Austin, Richard C

    MethodsX. 2019, v. 6

    2019  

    Abstract: Cell death is a common driver of human disease and is frequently studied in a variety of in vitro settings. There currently exists a range of commercially available assays to examine cell death, however, most are costly and require assay-specific ... ...

    Abstract Cell death is a common driver of human disease and is frequently studied in a variety of in vitro settings. There currently exists a range of commercially available assays to examine cell death, however, most are costly and require assay-specific experimental conditions that may not be suitable for many cell types. Here, we show that cellular debris occurring as a result of cell death can be used to quantify cell death using trypan blue. Furthermore, we demonstrate that the data generated using this technique are comparable to the widely-used lactate dehydrogenase (LDH) assay. Overall, we describe a novel application for trypan blue, a stain found in most biology laboratories, as a novel and cost-effective method for the quantification of cell death via staining of cell debris.
    Keywords cell death ; cost effectiveness ; human diseases ; lactate dehydrogenase ; staining
    Language English
    Size p. 1174-1180.
    Publishing place Elsevier B.V.
    Document type Article
    ISSN 2215-0161
    DOI 10.1016/j.mex.2019.05.010
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article ; Online: Pharmacologic inhibition of S1P attenuates ATF6 expression, causes ER stress and contributes to apoptotic cell death.

    Lebeau, Paul / Byun, Jae Hyun / Yousof, Tamana / Austin, Richard C

    Toxicology and applied pharmacology

    2018  Volume 349, Page(s) 1–7

    Abstract: Mammalian cells express unique transcription factors embedded in the endoplasmic reticulum (ER) membrane, such as the sterol regulatory element-binding proteins (SREBPs), that promote de novo lipogenesis. Upon their release from the ER, the SREBPs ... ...

    Abstract Mammalian cells express unique transcription factors embedded in the endoplasmic reticulum (ER) membrane, such as the sterol regulatory element-binding proteins (SREBPs), that promote de novo lipogenesis. Upon their release from the ER, the SREBPs require proteolytic activation in the Golgi by site-1-protease (S1P). As such, inhibition of S1P, using compounds such as PF-429242 (PF), reduces cholesterol synthesis and may represent a new strategy for the management of dyslipidemia. In addition to the SREBPs, the unfolded protein response (UPR) transducer, known as the activating transcription factor 6 (ATF6), is another ER membrane-bound transcription factor that requires S1P-mediated activation. ATF6 regulates ER protein folding capacity by promoting the expression of ER chaperones such as the 78-kDa glucose-regulated protein (GRP78). ER-resident chaperones like GRP78 prevent and/or resolve ER polypeptide accumulation and subsequent ER stress-induced UPR activation by folding nascent polypeptides. Here we report that pharmacological inhibition of S1P reduced the expression of ATF6 and GRP78 and induced the activation of UPR transducers inositol-requiring enzyme-1α (IRE1α) and protein kinase RNA-like ER kinase (PERK). As a consequence, S1P inhibition also increased the susceptibility of cells to ER stress-induced cell death. Our findings suggest that S1P plays a crucial role in the regulation of ER folding capacity and also identifies a compensatory cross-talk between UPR transducers in order to maintain adequate ER chaperone expression and activity.
    MeSH term(s) Activating Transcription Factor 6/antagonists & inhibitors ; Activating Transcription Factor 6/biosynthesis ; Animals ; Apoptosis/drug effects ; Apoptosis/genetics ; Cell Line ; Endoplasmic Reticulum Chaperone BiP ; Endoplasmic Reticulum Stress/drug effects ; Endoplasmic Reticulum Stress/genetics ; Endoribonucleases/antagonists & inhibitors ; Endoribonucleases/metabolism ; Enzyme Activation/drug effects ; Heat-Shock Proteins/biosynthesis ; Hepatocytes/drug effects ; Humans ; Mice ; Mice, Inbred C57BL ; Molecular Chaperones/biosynthesis ; Protein Serine-Threonine Kinases/antagonists & inhibitors ; Protein Serine-Threonine Kinases/metabolism ; Reactive Oxygen Species ; Sp1 Transcription Factor/antagonists & inhibitors ; Unfolded Protein Response/drug effects ; eIF-2 Kinase/antagonists & inhibitors ; eIF-2 Kinase/metabolism
    Chemical Substances ATF6 protein, human ; Activating Transcription Factor 6 ; Endoplasmic Reticulum Chaperone BiP ; HSPA5 protein, human ; Heat-Shock Proteins ; Hspa5 protein, mouse ; Molecular Chaperones ; Reactive Oxygen Species ; Sp1 Transcription Factor ; SP1 protein, human ; EIF2AK3 protein, human (EC 2.7.11.1) ; ERN1 protein, human (EC 2.7.11.1) ; Protein Serine-Threonine Kinases (EC 2.7.11.1) ; eIF-2 Kinase (EC 2.7.11.1) ; Endoribonucleases (EC 3.1.-)
    Language English
    Publishing date 2018-04-22
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 204477-8
    ISSN 1096-0333 ; 0041-008X
    ISSN (online) 1096-0333
    ISSN 0041-008X
    DOI 10.1016/j.taap.2018.04.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: The trypan blue cellular debris assay: a novel low-cost method for the rapid quantification of cell death.

    Lebeau, Paul F / Chen, Jack / Byun, Jae Hyun / Platko, Khrystyna / Austin, Richard C

    MethodsX

    2019  Volume 6, Page(s) 1174–1180

    Abstract: Cell death is a common driver of human disease and is frequently studied in a variety ... ...

    Abstract Cell death is a common driver of human disease and is frequently studied in a variety of
    Language English
    Publishing date 2019-05-15
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2215-0161
    ISSN 2215-0161
    DOI 10.1016/j.mex.2019.05.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing

    Lebeau, Paul F / Byun, Jae Hyun / Platko, Khrystyna / MacDonald, Melissa E / Poon, Samantha V / Faiyaz, Mahi / Seidah, Nabil G / Austin, Richard C

    The Journal of biological chemistry

    2019  Volume 294, Issue 23, Page(s) 9037–9047

    Abstract: The worldwide prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing rapidly. Although this condition is generally benign, accumulating evidence now suggests that patients with NAFLD are also at increased risk of cardiovascular disease ( ... ...

    Abstract The worldwide prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing rapidly. Although this condition is generally benign, accumulating evidence now suggests that patients with NAFLD are also at increased risk of cardiovascular disease (CVD); the leading cause of death in developed nations. Despite the well-established role of the liver as a central regulator of circulating low-density lipoprotein (LDL) cholesterol levels, a known driver of CVD, the mechanism(s) by which hepatic steatosis contributes to CVD remains elusive. Interestingly, a recent study has shown that circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) levels correlate positively with liver steatosis grade. Given that PCSK9 degrades the LDL receptor (LDLR) and prevents the removal of LDL from the blood into the liver, in the present study we examined the effect of hepatic steatosis on LDLR expression and circulating LDL cholesterol levels. We now report that in a manner consistent with findings in patients, diet-induced steatosis increases circulating PCSK9 levels as a result of
    MeSH term(s) Animals ; Apolipoproteins B/blood ; Cholesterol, LDL/blood ; Diet, High-Fat ; Endoplasmic Reticulum Stress/drug effects ; Fatty Liver/metabolism ; Fatty Liver/pathology ; Hep G2 Cells ; Humans ; Liver/metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Organophosphorus Compounds/pharmacology ; Proprotein Convertase 9/blood ; Proprotein Convertase 9/genetics ; Proprotein Convertase 9/metabolism ; Receptors, LDL/genetics ; Receptors, LDL/metabolism ; Sterol Regulatory Element Binding Protein 2/genetics ; Sterol Regulatory Element Binding Protein 2/metabolism
    Chemical Substances Apolipoproteins B ; Cholesterol, LDL ; Organophosphorus Compounds ; Receptors, LDL ; Sterol Regulatory Element Binding Protein 2 ; N-hydroxy-4-phosphonobutanamide (146086-80-8) ; Pcsk9 protein, mouse (EC 3.4.21.-) ; Proprotein Convertase 9 (EC 3.4.21.-)
    Language English
    Publishing date 2019-04-19
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.RA119.008094
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top